These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
651 related items for PubMed ID: 18371553
1. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC. J Am Coll Cardiol; 2008 Apr 01; 51(13):1247-54. PubMed ID: 18371553 [Abstract] [Full Text] [Related]
2. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC. Am J Cardiol; 2007 Oct 01; 100(7):1061-7. PubMed ID: 17884362 [Abstract] [Full Text] [Related]
3. Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction. Winkelmayer WC, Charytan DM, Levin R, Avorn J. Am J Kidney Dis; 2006 Feb 01; 47(2):301-8. PubMed ID: 16431259 [Abstract] [Full Text] [Related]
4. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction. Sun SX, Ye X, Lee KY, Dupclay L, Plauschinat C. Clin Ther; 2008 Feb 01; 30 Pt 2():2217-27. PubMed ID: 19281916 [Abstract] [Full Text] [Related]
5. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction. Austin PC, Tu JV, Ko DT, Alter DA. CMAJ; 2008 Oct 21; 179(9):901-8. PubMed ID: 18936455 [Abstract] [Full Text] [Related]
6. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery. Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB, Peterson ED, PREVENT IV Investigators. Ann Thorac Surg; 2007 Mar 21; 83(3):993-1001. PubMed ID: 17307447 [Abstract] [Full Text] [Related]
7. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis. van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A. Clin Ther; 2005 Nov 21; 27(11):1806-14. PubMed ID: 16368451 [Abstract] [Full Text] [Related]
10. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value. Lee JH, Yang DH, Park HS, Cho Y, Jeong MH, Kim YJ, Kim KS, Hur SH, Seong IW, Hong TJ, Cho MC, Kim CJ, Jun JE, Park WH, Chae SC, Korea Acute Myocardial Infarction Registry Investigators. Am Heart J; 2010 Jun 21; 159(6):1012-9. PubMed ID: 20569714 [Abstract] [Full Text] [Related]
11. Association of medical noncompliance and long-term adverse outcomes, after myocardial infarction in a minority and uninsured population. Amin AP, Mukhopadhyay E, Nathan S, Napan S, Kelly RF. Transl Res; 2009 Aug 21; 154(2):78-89. PubMed ID: 19595439 [Abstract] [Full Text] [Related]
12. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction. Gasse C, Jacobsen J, Larsen AC, Schmidt EB, Johannesen NL, Videbaek J, Sørensen HT, Johnsen SP. Eur J Vasc Endovasc Surg; 2008 Jan 21; 35(1):51-8. PubMed ID: 17923426 [Abstract] [Full Text] [Related]
14. Reducing post-myocardial infarction mortality in the elderly: the power and promise of secondary prevention. Boden WE, Maron DJ. J Am Coll Cardiol; 2008 Apr 01; 51(13):1255-7. PubMed ID: 18371554 [No Abstract] [Full Text] [Related]
15. Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization. Tuppin P, Neumann A, Danchin N, de Peretti C, Weill A, Ricordeau P, Allemand H. Arch Cardiovasc Dis; 2010 Apr 01; 103(6-7):363-75. PubMed ID: 20800800 [Abstract] [Full Text] [Related]
16. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care. Filippi A, D'Ambrosio G, Giustini SE, Pecchioli S, Mazzaglia G, Cricelli C. J Cardiovasc Med (Hagerstown); 2009 Sep 01; 10(9):714-8. PubMed ID: 19465867 [Abstract] [Full Text] [Related]
17. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials. Volpe M, Tocci G, Sciarretta S, Verdecchia P, Trimarco B, Mancia G. J Hypertens; 2009 May 01; 27(5):941-6. PubMed ID: 19381108 [Abstract] [Full Text] [Related]
18. Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction. Austin PC, Tu JV, Ko DT, Alter DA. CMAJ; 2008 Oct 21; 179(9):895-900. PubMed ID: 18936454 [Abstract] [Full Text] [Related]
19. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap? Hudson M, Richard H, Pilote L. Pharmacoepidemiol Drug Saf; 2007 Jul 21; 16(7):773-85. PubMed ID: 17486661 [Abstract] [Full Text] [Related]
20. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. Yan AT, Yan RT, Tan M, Huynh T, Soghrati K, Brunner LJ, DeYoung P, Fitchett DH, Langer A, Goodman SG, Canadian ACS Registries Investigators. Am Heart J; 2007 Dec 21; 154(6):1108-15. PubMed ID: 18035083 [Abstract] [Full Text] [Related] Page: [Next] [New Search]